Qube Research & Technologies (QRT)
VRAX icon

Qube Research & Technologies (QRT)’s Virax Biolabs VRAX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VRAX Stock Details VRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12
Closed -$348 – 4178
2024
Q2 		$348 Buy
+12
New +$297 ﹤0.01% 3342

Other funds holding VRAX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VRAX Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Virax Biolabs (VRAX) in Q3 2024, closing a stake of 12 shares — an estimated $348 sold.

Qube Research & Technologies (QRT) first reported a position in VRAX in Q2 2024 and held it in 1 quarter. The position peaked at $348 in Q2 2024. 5 funds tracked by Wall St. Rank hold VRAX as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Virax Biolabs position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12 Virax Biolabs shares in Q3 2024, an estimated $348.
  • Qube Research & Technologies (QRT) first reported a position in Virax Biolabs in Q2 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Virax Biolabs position peaked at $348 in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Virax Biolabs as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.